Published in Liver Transpl on May 01, 2003
Bacterial infection after liver transplantation. World J Gastroenterol (2014) 0.94
[Infections in organ transplantations]. Pathologe (2011) 0.78
Trends in brain-dead organ donor characteristics: a 13-year analysis. Can J Surg (2016) 0.76
Brain death and care of the organ donor. J Anaesthesiol Clin Pharmacol (2016) 0.75
Organ Donation : Intensive Care Issues in Managing Brain Dead. Med J Armed Forces India (2011) 0.75
The survival benefit of liver transplantation. Am J Transplant (2005) 5.08
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75
Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl (2004) 1.69
Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology (2004) 1.61
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology (2004) 1.57
Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl (2002) 1.57
The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity (2002) 1.56
In pursuit of the ideal liver allocation model. Liver Transpl (2002) 1.45
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Novel use of intravenous immunoglobulin G in complement factor H missense mutation: a case report. Prog Transplant (2013) 1.39
Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant (2005) 1.31
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology (2002) 1.17
Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine (2004) 1.15
Model for end-stage liver disease (MELD) exception guidelines. Liver Transpl (2006) 1.07
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl (2011) 1.02
Aerobic capacity is associated with 100-day outcome after hepatic transplantation. Liver Transpl (2004) 1.00
Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant (2004) 0.98
Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl (2002) 0.97
Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation (2008) 0.97
Optimizing the use of donated cadaver livers: analysis and policy development to increase the application of split-liver transplantation. Liver Transpl (2002) 0.95
Successful outcomes following living donor liver transplantation for portopulmonary hypertension. Liver Transpl (2010) 0.91
Gene expression profiling of renal cell carcinoma. Clin Cancer Res (2004) 0.89
Liver and intestine transplantation. Am J Transplant (2003) 0.83
MELD and liver allocation: continuous quality improvement. Hepatology (2004) 0.83
Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy. Am J Clin Oncol (2011) 0.80
Mathematical models and behavior: assessing delta MELD for liver allocation. Am J Transplant (2004) 0.79
Extent of right hepatectomy determines postoperative donor albumin and bilirubin changes: new insights. Liver Int (2007) 0.77
Liver transplantation for hepatocellular carcinoma: racial disparities? Am J Gastroenterol (2008) 0.77
The value of machine perfusion in deceased donor kidney transplantation. Am J Kidney Dis (2009) 0.76
Predicting the future? Liver Transpl (2007) 0.76
Organ donation. Semin Liver Dis (2009) 0.76
Mortality risk, behavior, and pediatric liver allocation. Liver Transpl (2006) 0.75
Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation. Liver Transpl (2014) 0.75
The price of "doing the right thing". Liver Transpl (2011) 0.75
Liver allocation for HCC: a moving target. Liver Transpl (2004) 0.75
Small steps versus big leaps in changing liver distribution policy. Liver Transpl (2011) 0.75
Transplantation: Sharing of donated livers is not equal. Nat Rev Gastroenterol Hepatol (2012) 0.75
MELD and the quality of life. Liver Transpl (2005) 0.75
Mortality risk versus other endpoints: who should come first on the liver transplant waiting list? Liver Transpl (2004) 0.75
Overcoming the ABO incompatibility barrier. Liver Transpl (2009) 0.75
Justice, administrative law, and the transplant clinician: the ethical and legislative basis of a national policy on donor liver allocation. J Contemp Health Law Policy (2007) 0.75
Should we change the priority for liver allocation for patients with the highest MELD score? Hepatology (2012) 0.75